about
Multiple DNA Binding Proteins Contribute to Timing of Chromosome Replication in E. coliOrigins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011.Control of bacterial chromosome replication by non-coding regions outside the origin.Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011.Control regions for chromosome replication are conserved with respect to sequence and location among Escherichia coli strains.DNA Replication Control Is Linked to Genomic Positioning of Control Regions in Escherichia coli.Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract InfectionPrevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.Heat resistance in extended-spectrum beta-lactamase-producing Escherichia coli may favor environmental survival in a hospital setting.The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota.Oxidative DNA damage is instrumental in hyperreplication stress-induced inviability of Escherichia coli.Determination of the Optimal Chromosomal Location(s) for a DNA Element in Escherichia coli Using a Novel Transposon-mediated Approach.Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hostsEfflux-Pump Upregulation: From Tolerance to High-level Antibiotic Resistance?
P50
Q26742071-E63B8424-FD34-42BB-9FE1-0AA74C185869Q28244221-56D90D2D-9B49-4065-8EB0-3DE576551380Q33395906-E52713F5-7C8B-4975-AD44-2C7128A43716Q34547145-42194785-2825-4CD2-AB39-7B71F70F5A42Q34596717-B425E7B1-0BA1-4F2D-9D05-18E64802480DQ35779118-5DA7B14E-91DF-4D60-A40E-B59A0F5B1DF3Q36098329-001A4566-6D3A-4741-8FF3-A6371FE2B54FQ36121619-E443903D-0E07-4EB4-88FB-88DF938228F3Q36891288-76FD55E6-7AE7-4995-952B-22FCB2AA20C1Q37026380-E5E1F1A0-F7FF-40E0-B302-8402D4CA8DC3Q37546369-2481EF46-6CE0-4277-B2C5-B0BE0DE0F805Q40766478-1846CD10-DB28-4355-9889-93EB8AB5C17EQ41769005-33006E6C-5EC3-43E6-8440-E77095FD3656Q41811490-C34EEA5B-2047-4B6C-86BE-BC6D1521C4C7Q49989258-90A86C85-342D-41C3-AF5D-8F9078F2BF52Q57806910-74DFF7A8-F597-4609-ABEE-04B674D051F6Q91631052-F113BDD6-DFB7-44CE-A15F-8D0E915E1344
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jakob Frimodt-Møller
@ast
Jakob Frimodt-Møller
@en
Jakob Frimodt-Møller
@es
Jakob Frimodt-Møller
@nl
type
label
Jakob Frimodt-Møller
@ast
Jakob Frimodt-Møller
@en
Jakob Frimodt-Møller
@es
Jakob Frimodt-Møller
@nl
prefLabel
Jakob Frimodt-Møller
@ast
Jakob Frimodt-Møller
@en
Jakob Frimodt-Møller
@es
Jakob Frimodt-Møller
@nl
P106
P108
P21
P31
P496
0000-0002-7585-636X